Funding Opportunities

  1. Implementation Science
  2. Funding Opportunities

The NCI, along with institutes and centers across the National Institutes of Health, supports rigorous, cutting-edge implementation science (also referred to as “dissemination and implementation research”) grants through a variety of funding opportunities. The program supports investigator-initiated research grants and sponsors or co-sponsors a variety of targeted notices of funding opportunities (NOFOs). Learn more about these opportunities and find resources for prospective IS applicants.

Notices of Funding Opportunities

IS Funding Opportunities

There are many funding opportunities that support the conduct of dissemination and implementation research at NCI and across the NIH.

Current IS Funding Opportunities and Previous Grants

Current and previous grants funded through the DIRH NOFO in cancer prevention and control by DCCPS are listed in a searchable table for reference.

NIH-wide PAR, Dissemination and Implementation Research in Health

The NIH-wide NOFO with special receipt, referral and/or review (PAR), Dissemination and Implementation Research in Health (DIRH) issued the PAR for R01, R21, and/or R03 funding sources.

R01, Dissemination and Implementation Research in Health (PAR-25-144, Clinical Trial Optional)

This funding opportunity provides research project grants to support discrete, specified research projects led by an investigator in a topic area representing his or her specific interests and competencies. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. Applications may not exceed 5 years.

R21, Dissemination and Implementation Research in Health (PAR-25-143, Clinical Trial Optional)

This funding opportunity provides grants that are intended to encourage exploratory or developmental research projects by supporting the development of pilot projects or feasibility studies to support creative, novel, and high-risk/high-payoff research. Applicants may request a project period of up to 2 years and the combined budget for direct costs may not exceed $275,000.

R03, Dissemination and Implementation Research in Health (PAR-25-233, Clinical Trial Not Allowed)

This funding opportunity provides small research grants to support the initiation of studies that are generally for preliminary short-term projects. Applicants for an R03 award may request a project period of up to 2 years and a budget for direct costs of up to $50,000 per year. While the grant is nonrenewable, there is less competition for these start-up research project funds.

Successful Grant Applications

View excerpts from successfully funded research grant applications to help prepare applications for NCI funding.

Sample Grant Applications

Funding Inquiry Staff Contact

Gila Neta Gila Neta, PhD, MPP
Program Director
gila.neta@nih.gov

Norton Wynne E. Norton, PhD
Program Director
wynne.norton@nih.gov

Additional Resources

Informational Webinar 2024

Learn about NCI’s participation in the set of NIH announcements, “Dissemination and Implementation Research in Health (R01/R21 - Clinical Trial Optional, R03 – Clinical Trial Not Allowed).

Webinar

Study Section

The Science of Implementation in Health and Healthcare (SIHH) Study Section reviews applications that identify, develop, and evaluate dissemination and implementation theories, strategies and methods designed to integrate evidence-based health interventions into public health, clinical, and community settings. Applications reviewed in SIHH should have a major methods, strategy, or theoretical development component in implementation science in order to understand how interventions are implemented and measure implementation outcomes in public health, clinical, and community settings.

Membership and Meeting Rosters

Portfolio Analysis

  • Neta G, Clyne M, Chambers DA. Dissemination and Implementation Research at the National Cancer Institute: A Review of Funded Studies (2006-2019) and Opportunities to Advance the Field. Cancer Epidemiol Biomarkers Prev. 2021;30(2):260-267. doi:1158/1055-9965.EPI-20-0795.
  • Neta G, Sanchez MA, Chambers DA, et al. Implementation science in cancer prevention and control: a decade of grant funding by the National Cancer Institute and future directions. Implement Sci. 2015;10:4. Published 2015 Jan 8. doi:1186/s13012-014-0200-2.

Search NCI-Funded Portfolios